Immune checkpoint proteins are molecules expressed on the surface of T-cells, which are crucial players in the immune system. These proteins play a critical role in maintaining immune homeostasis by regulating the intensity and duration of immune responses. They essentially act as brakes to prevent overactivation of the immune system, which could otherwise lead to autoimmune diseases. In the context of cancer, however, tumors can exploit these checkpoints to avoid being attacked by the immune system.
